Global Longlife Hospital and R
BSE: GLHRL · Hospital · sector
₹12.37BSE close 2026-10-26
Key numbers
Market cap₹13 cr
Price₹12.37
52w high / low₹26 / ₹9
P/E7.5xSector median 42.5x
P/B1.0xSector median 4.9x
Book value₹12.6
Dividend yield–Sector median 0.17%
ROE-11.6%Sector median 12.1%
ROCE-7.5%Sector median 13.8%
OPM–Sector median 20.3%
Debt / equity–Sector median 0.24x
EV/EBITDA–Sector median 23.6x
Interest cover-3,292.3x
Current ratio1,691.15x
Sales growth 3y–Sector median +14.1%
Profit growth 3y–Sector median +14.7%
PEG–
Last 12 months to Mar 2026, Standalone. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest -3,292.3x in the last 12 months.
- Net loss in 3 of the last 3 quarters.
- No dividend in the last 5 financial years.
- Price ₹12.37 on 2026-10-26: -52.1% from the 52-week high, +37.4% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹36.00 · low ₹9.96
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| EBITDA | -0 | -1 | -0 |
| OPM % | – | – | – |
| Other income | -1 | 0 | 0 |
| Net profit | -1 | -1 | -0 |
| EPS (₹) | 0.99 | 1.26 | 0.38 |
Standalone figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 33 | 24 | 14 | 1 | 0 | 0 |
| EBITDA | 8 | 4 | -0 | -4 | -1 | -1 |
| Net profit | 4 | 2 | -2 | 0 | -2 | -2 |
| EPS (₹) | 5.11 | 1.80 | -2.08 | 0.19 | 1.64 | 1.64 |
| Revenue growth | -28.4% | -42.5% | -95.7% | -100.0% | – | |
| Profit growth | -48.7% | -219.7% | – | -960.0% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | -3.1% | – | – |
| Share price | – | -40.2% (2y) | -43.7% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 16 | 13 |
| Cash & equivalents | 21 | 17 |
| Total assets | 27 | 24 |
| Fixed assets | 0 | 0 |
| Investments | 0 | 0 |
| Inventory | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 12 | -5 |
| Cash from investing | 22 | 0 |
| Cash from financing | -13 | 0 |
| Capex | 0 | 0 |
| Free cash flow | 12 | -5 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 1.2% | -13.0% |
| ROCE % | 2.3% | -7.5% |
| Inventory days | 0 | – |
| Working capital days | 14,277 | – |
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| GLHRL | ₹13 cr | 7.5x | 1.0x | -11.6% | -7.5% | – | – | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | GLHRL |
| BSE code | 543520 |
| ISIN | INE0J2K01014 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.